Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report

Author：                  

Publisher： Spandidos Publications

E-ISSN： 1792-1082|9|4|1537-1540

ISSN： 1792-1074

Source： Oncology Letters, Vol.9, Iss.4, 2015-01, pp. : 1537-1540

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful rechallenge with reduced dose of erlotinib in a patient with lung adenocarcinoma who developed erlotinibassociated leukocytoclastic vasculitis: A case report

By Su Bo-An   Shen Wan-Lin   Chang Sheng-Tsung   Feng Li-Yia   Wu Chia-Jung   Feng Yin-Hsun  

Oncology Letters, Vol. 3, Iss. 6, 2012-06 ,pp. : 1280-1282

Spandidos Publications

Access to resources Recommend Favorite

EML4-ALK translocation is associated with early onset of disease and other clinicopathological features in Chinese female never-smokers with non-small-cell lung cancer

By              

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3385-3392

Spandidos Publications

Access to resources Recommend Favorite

A case of lung adenocarcinoma with a concurrent EGFR mutation and ALK rearrangement: A case report and literature review

By                    

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 4370-4375

Spandidos Publications

Access to resources Recommend Favorite

EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 4, 2016-11 ,pp. : 393-400

Bentham Science Publishers

Access to resources Recommend Favorite

Isolated spleen recurrence in a patient with lung adenocarcinoma: A case report

By            

Experimental and Therapeutic Medicine, Vol. 10, Iss. 2, 2015-01 ,pp. : 733-736

Spandidos Publications

Access to resources Recommend Favorite